CU23422B7 - HIDROXI-TETRAHIDRO-NAFTALENILUREA DERIVATIVES - Google Patents

HIDROXI-TETRAHIDRO-NAFTALENILUREA DERIVATIVES

Info

Publication number
CU23422B7
CU23422B7 CU20040254A CU20040254A CU23422B7 CU 23422 B7 CU23422 B7 CU 23422B7 CU 20040254 A CU20040254 A CU 20040254A CU 20040254 A CU20040254 A CU 20040254A CU 23422 B7 CU23422 B7 CU 23422B7
Authority
CU
Cuba
Prior art keywords
pain
derivatives
tetrahydro
useful
treatment
Prior art date
Application number
CU20040254A
Other languages
Spanish (es)
Inventor
Yasuhiro Tsukimi
Masaomi Tajimi
Mashiro Shiroo
Toshiya Moriwaki
Hiroshi Fujishima
Klaus Urbahns
Tsutomu Masuda
Nagahiro Yoshida
Nuriyuki Yamamoto
Muneto Mogi
Toshio Kokubo
Takeshi Yura
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CU23422B7 publication Critical patent/CU23422B7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se refiere a derivados de tetrahidro-naftaleno y a sales del mismo que son útiles como ingredientes activo de preparaciones farcéuticas. Los derivados de tetrahidro-naftaleno de la presente invención tienen una excelente actividad como antagonista de VR1 y es útil para la prevención y tratamiento de enfermedades relacianadas con la actividad de VR1, en particular para el tratamiento de incontinencia urinaria de urgencia , vejiga hiperactiva, dolor crónico, dolor neuropático, dolor postoperatorio, dolor por artritis reumatoide, neuralgia, neuropatías, algesia, lesión nerviosa, isquemia, neurodegeneración, apoplejía, incontinencia, trastornos inflamatorios, asma y COPD.This invention relates to tetrahydro-naphthalene derivatives and salts thereof that are useful as active ingredients of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have excellent activity as an antagonist of VR1 and is useful for the prevention and treatment of diseases related to the activity of VR1, in particular for the treatment of urinary incontinence of urgency, overactive bladder, pain Chronic, neuropathic pain, postoperative pain, rheumatoid arthritis pain, neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, stroke, incontinence, inflammatory disorders, asthma and COPD.

CU20040254A 2002-05-08 2004-11-04 HIDROXI-TETRAHIDRO-NAFTALENILUREA DERIVATIVES CU23422B7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210512.0A GB0210512D0 (en) 2002-05-08 2002-05-08 Tetrahydro-napthalene derivatives
GBGB0227262.3A GB0227262D0 (en) 2002-05-08 2002-11-21 Tetrahydro-naphthalene derivatives

Publications (1)

Publication Number Publication Date
CU23422B7 true CU23422B7 (en) 2009-09-08

Family

ID=9936269

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20040254A CU23422B7 (en) 2002-05-08 2004-11-04 HIDROXI-TETRAHIDRO-NAFTALENILUREA DERIVATIVES

Country Status (13)

Country Link
KR (1) KR101000688B1 (en)
AR (1) AR039983A1 (en)
CU (1) CU23422B7 (en)
DO (1) DOP2003000642A (en)
EC (1) ECSP045413A (en)
GB (2) GB0210512D0 (en)
GT (1) GT200300102A (en)
MA (1) MA30728B1 (en)
MY (1) MY155011A (en)
PE (1) PE20040363A1 (en)
PT (1) PT1506167E (en)
UA (1) UA77301C2 (en)
ZA (1) ZA200408993B (en)

Also Published As

Publication number Publication date
KR20040108784A (en) 2004-12-24
PE20040363A1 (en) 2004-07-03
ECSP045413A (en) 2005-01-03
DOP2003000642A (en) 2003-11-15
KR101000688B1 (en) 2010-12-10
PT1506167E (en) 2007-12-10
GB0227262D0 (en) 2002-12-31
AR039983A1 (en) 2005-03-09
MA30728B1 (en) 2009-10-01
GT200300102A (en) 2004-03-17
MY155011A (en) 2015-08-28
UA77301C2 (en) 2006-11-15
GB0210512D0 (en) 2002-06-19
ZA200408993B (en) 2006-01-25

Similar Documents

Publication Publication Date Title
HK1082946A1 (en) Hydroxy tetrahydro-naphthalenyurea derivatives
ATE370118T1 (en) TETRAHYDRONAPHTALENE DERIVATIVES
AR058679A1 (en) PHARMACEUTICAL PREPARATION CONTAINING MELOXICAM
BR112014017780A8 (en) TRICYCLIC SULPHONE COMPOUNDS AND METHODS FOR MAKING AND USING THEM
BR112012025015A2 (en) pharmaceutical formulations for treating overactive bladder.
EA200702204A1 (en) TREATMENT OF DISEASES OF THE CONNECTIVE TISSUE OF THE SKIN
UA110013C2 (en) APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS
AR040248A1 (en) PHARMACO FOR THE TREATMENT OF HYPERACTIVE BLADDER
WO2011056033A3 (en) Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
CL2008002747A1 (en) Compounds derived from furo and thienopyrimidine; pharmaceutical composition; method of modulating histamine h4 receptor activity; and use in the treatment of disorders such as inflammation, allergic and dermatological disorders, among others.
DK1572632T3 (en) Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
ATE442864T1 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLVENT ACTIVE
AR081253A1 (en) USE OF DIATOME LAND IN THE PHARMACEUTICAL INDUSTRY
CU23422B7 (en) HIDROXI-TETRAHIDRO-NAFTALENILUREA DERIVATIVES
UY27794A1 (en) DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA
NO20064196L (en) External preparation for the treatment of painful skin damage
PA8579701A1 (en) BETA-LACTAMASA INHIBITOR PROFARMACO
ITMI20031941A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS FOR DERMATITIS TREATMENT
BR112013015489A2 (en) combination and composition for obesity treatment
UA60688U (en) pharmaceutical composition for the treatment of respiratory diseases and allergic diseases
UY31669A1 (en) &#34;PHARMACEUTICAL FORMULATION THAT INCLUDES OXABISPIDINS / 236&#34;
DOP2004001047A (en) CHROMAN DERIVATIVES
UY26840A1 (en) PHARMACEUTICAL COMPOSITION BASED ON COCAETHYLENE AND ITS USE FOR THE TREATMENT OF DEPENDENCE ON PSYCHOACTIVE SUBSTANCES
BRPI0600799B8 (en) pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or its pharmaceutically acceptable salt for cutaneous application, its preparation process and uses